ISPC
iSpecimen Inc.NASDAQHealthcare$0.14-6.45%ClosedMarket Cap: $789,847
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.23
P/S
0.44
EV/EBITDA
0.64
DCF Value
$-1.19
FCF Yield
-499.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
1.2%
Operating Margin
-465.4%
Net Margin
-543.7%
ROE
-496.4%
ROA
-110.0%
ROIC
-267.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $1.9M | 1.2% | $-9.0M | $-10.5M | $-2.28 | — |
| Q3 2025 | $106.6K | -91.9% | $-2.8M | $-2.8M | $-0.48 | — |
| Q2 2025 | $713.1K | 37.7% | $-1.8M | $-1.0M | $-0.42 | — |
| Q1 2025 | $1.1M | 37.8% | $-1.6M | $-1.7M | $-2.33 | — |
| Q4 2024 | $1.5M | 10.3% | $-5.8M | $-6.0M | $-8.51 | — |
| FY 2024 | $9.3M | 42.9% | $-12.7M | $-12.5M | $-17.58 | — |
| Q3 2024 | $2.7M | 41.6% | $-1.7M | $-1.4M | $-2.10 | — |
| Q2 2024 | $2.9M | 50.3% | $-2.2M | $-2.1M | $-3.72 | — |
| Q1 2024 | $2.3M | 56.3% | $-3.0M | $-2.9M | $-6.36 | — |
| Q4 2023 | $2.6M | 44.6% | $-2.9M | $-3.1M | $-6.77 | — |
| FY 2023 | $9.9M | 51.4% | $-11.2M | $-11.1M | $-24.55 | — |
| Q3 2023 | $2.8M | 49.9% | $-2.2M | $-2.1M | $-4.66 | — |